Clinical Trial Update: Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating treatment for opioid-induced constipation in adults with persistent non-cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Opioid-induced Constipation

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Bowel Dysfunction, Constipation | Phase 3 | Status: COMPLETED